DelSiTech and Tolmar Announce Global License and Development Agreement

Tolmar secures global license to DelSiTech's Silica Matrix technology to develop and commercialize two undisclosed drug targetsDelSiTech and Tolmar to expand development of additional drug products across a range of therapeutic areasDelSiTech is eligible to receive upfront payments, development and commercial milestone payments, and royalties on licensed productsView original content:https://www.prnewswire.co.uk/news-releases/delsitech-and-tolmar-announce-global-license-and-development-agreement-302059766.html

en | boerse | 67934471 |